A new company under financial investment firm SOL Partnership has launched what could be the first at-home gut health test service powered by AI in Malaysia.
SpaceGut offers an at-home gut microbiome kit and a laboratory service that provides personalised recommendations for an individual's gut health. Leveraging a proprietary AI, its laboratory evaluates samples compared against a database of...
Singapore-based precision gut microbiome company AMILI has snapped up $10.5 million in a Series A funding round led by technology and life sciences investor Vulcan Capital.
New investors also joined the round, including Pruksa Group, TVM Capital Healthcare, Emtek Group, Capital Code, Pureland Group, Blue7 and Enterprise Singapore's investment arm SEEDS Capital.
WHAT IT DOES
Founded in 2019, the...
Viome Life Sciences announced Wednesday it had raised $54 million in a pre-Series C convertible funding round.
Participants in the round include existing investors Khosla Ventures, West River Group, Glico, Physician Partners and Bold Capital Group alongside new investor Ocgrow Ventures.
Viome said this latest investment brings its total capitalization to $125 million.
WHAT THEY DO
Viome is split...
At-home microbiome testing company Ombre, formerly Thryve, has raised $3 million in seed funding, bringing its total raise to $9.5 million.
The round was led by PivotNorth Capital with participation from Trail Mix Ventures, Shanda Group, Unilever Ventures, Social Starts' fund Joyance Partners and Unpopular Ventures.
In addition to the name change, the company also hired new CEO Elise Contarsy,...
Viome Life Sciences, maker of at-home tests for gut and immune system health, is expanding its partnership with global pharma company GlaxoSmithKline to research and potentially develop interventions for some cancers and autoimmune diseases.
The collaboration will allow the companies to study the connection between the gut microbiome and some chronic diseases, like autoimmune disorders. Viome...
Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that detect early signs of oral cancer and throat cancer.
The FDA designation validates the technology used in Viome’s at-home Health Intelligence Test that analyzes users’ microbial, human and mitochondrial...
DayTwo, an Israeli company that analyzes gut microbiomes to assist with nutrition and glycemic control, has raised $31 million in Series B financing. Ofek Ventures and aMoon led the round, with additional support coming from prior backers Seventure Partners and Johnson & Johnson.
With this, the company brings its total backing to $48 million.
WHAT THEY DO
DayTwo’s platform asks patients to...
DayTwo, an Israeli startup focused on delivering insights to consumers based on their gut microbiome, has raised $12 million from an impressive suite of investors including Johnson & Johnson Innovation and the Mayo Clinic. Seventure Partners' Health for Life Capital Fund also contributed along with private investors including cofounder Marius Nacht.
The startup, which has raised $17 million...
San Francisco-based uBiome, which makes a direct-to-consumer microbial genomic testing kit, has closed on a $22 million Series B funding round, led by 8VC with additional funding from Slow Ventures, Stanford’s StartX Fund and various angel investors. The funding will be used to deploy uBiome’s new testing kit, SmartGut, a sequencing-based clinical microbiome screening test.
With an at-home...
Seattle-based Arivale, which offers a testing kit and companion app to create tailored wellness plans, is now available in California.
Billed as the “scientific path to wellness,” Arivale offers people a package that includes a Fitbit, collection containers for saliva, urine, cheek swabs, and a prescribed order of blood tests to do on their own time, plus a companion app. Users download the app...
